Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rickie Patani

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Nature Communications|May 24, 2018
Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALSRaphaelle Luisier, Giulia E Tyzack, Claire E Hall, et al.
Journal of Neurotrauma|August 28, 2019
Delineating Astrocytic Cytokine Responses in a Human Stem Cell Model of Neural TraumaEric Peter Thelin, Claire E Hall, Giulia E Tyzack, et al.
Nature Communications|October 29, 2017
A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS modelsGiulia E Tyzack, Claire E Hall, Christopher R Sibley, et al.
Science Advances|August 22, 2025
An alternative cytoplasmic SFPQ isoform with reduced phase separation potential is up-regulated in ALSJacob Neeves, Marija Petrić Howe, Oliver J Ziff, et al.
Nature Communications|April 20, 2023
Integrated transcriptome landscape of ALS identifies genome instability linked to TDP-43 pathologyOliver J Ziff, Jacob Neeves, Jamie Mitchell, et al.
Nature Neuroscience|March 2, 2011
Characterizing the RNA targets and position-dependent splicing regulation by TDP-43James R Tollervey, Tomaž Curk, Boris Rogelj, et al.
Life Science Alliance|July 12, 2023
Transcriptome-wide RNA binding analysis of C9orf72 poly(PR) dipeptidesRubika Balendra, Igor Ruiz de Los Mozos, Hana M Odeh, et al.
Brain : a Journal of Neurology|January 18, 2022
Astrocytes display cell autonomous and diverse early reactive states in familial amyotrophic lateral sclerosisDoaa M Taha, Benjamin E Clarke, Claire E Hall, et al.
Journal of Cellular and Molecular Medicine|December 24, 2021
Elevated 4R-tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutationNúria Setó-Salvia, Noemi Esteras, Rohan de Silva, et al.
The Lancet. Neurology|January 13, 2012
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept studyPeter Connick, Madhan Kolappan, Charles Crawley, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Nature Communications|May 24, 2018
Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALSRaphaelle Luisier, Giulia E Tyzack, Claire E Hall, et al.
Journal of Neurotrauma|August 28, 2019
Delineating Astrocytic Cytokine Responses in a Human Stem Cell Model of Neural TraumaEric Peter Thelin, Claire E Hall, Giulia E Tyzack, et al.
Nature Communications|October 29, 2017
A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS modelsGiulia E Tyzack, Claire E Hall, Christopher R Sibley, et al.
Science Advances|August 22, 2025
An alternative cytoplasmic SFPQ isoform with reduced phase separation potential is up-regulated in ALSJacob Neeves, Marija Petrić Howe, Oliver J Ziff, et al.
Nature Communications|April 20, 2023
Integrated transcriptome landscape of ALS identifies genome instability linked to TDP-43 pathologyOliver J Ziff, Jacob Neeves, Jamie Mitchell, et al.
Nature Neuroscience|March 2, 2011
Characterizing the RNA targets and position-dependent splicing regulation by TDP-43James R Tollervey, Tomaž Curk, Boris Rogelj, et al.
Life Science Alliance|July 12, 2023
Transcriptome-wide RNA binding analysis of C9orf72 poly(PR) dipeptidesRubika Balendra, Igor Ruiz de Los Mozos, Hana M Odeh, et al.
Brain : a Journal of Neurology|January 18, 2022
Astrocytes display cell autonomous and diverse early reactive states in familial amyotrophic lateral sclerosisDoaa M Taha, Benjamin E Clarke, Claire E Hall, et al.
Journal of Cellular and Molecular Medicine|December 24, 2021
Elevated 4R-tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutationNúria Setó-Salvia, Noemi Esteras, Rohan de Silva, et al.
The Lancet. Neurology|January 13, 2012
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept studyPeter Connick, Madhan Kolappan, Charles Crawley, et al.
Pageof 11